Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

No single treatment is clearly effective for central serous chorioretinopathy.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Heavy ion radiation has a more severe and long-lasting effect on mouse intestinal metabolites than gamma radiation.

Gray hair may be caused by lower antioxidant activity in hair cells.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

BMP signaling is essential for the development of touch domes.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The best method for urethral reconstruction is using hypoxia-preconditioned stem cells with autologous cells on a vascularized synthetic scaffold.

The supplement helps improve hair growth and reduce hair shedding.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Using extracellular vesicles from stem cells can help hair grow by affecting scalp cells and hair follicles.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.